Oxidative stress-induced DNA damage by manganese dioxide nanoparticles in human neuronal cells
10.1155/2017/5478790 · 2017
Doxorubicin–loaded pH–responsive porphyrin–derived carbon dots as a promising biocompatible drug delivery system for effective chemotherapy of breast cancer
10.1039/d4ra09058f · 2025
Latest nanoparticles to modulate hypoxic microenvironment in photodynamic therapy of cervical cancer: a review of in vivo studies
10.3390/ijms26178503 · 2025
Advances in doxorubicin chemotherapy: emerging polymeric nanocarriers for drug loading and delivery
10.3390/cancers17142303 · 2025
Assembled gold superstructure triggered synergistic apoptosis/ferroptosis via combined photo–enzyme therapy
10.1021/acsami.5c20328 · 2025
Biomedical application of manganese dioxide nanomaterials
2020
Folic acid–modified erythrocyte membrane loading dual drug for targeted and chemo–photothermal synergistic cancer therapy
10.1021/acs.molpharmaceut.0c01008 · 2021
Self–assembled nano–multiple warheads: a precise targeting platform for combinatorial chemotherapy, PTT and PDT therapy against glioma
10.1016/j.bioadv.2026.215132 · 2026
Erythrocyte membrane–liposome coating sustains circulation stability and targeted tumor therapy of CAR–T cells
2026
Functions of red cell surface proteins
10.1111/j.1423-0410.2007.00970.x · 2007
Red blood cell membrane vesicles for siRNA delivery: a biocompatible carrier with passive tumor targeting and prolonged plasma residency
10.2147/ijn.s504644 · 2025
An innovative MWCNTs/DOX/TC nanosystem for chemo–photothermal combination therapy of cancer
10.1016/j.nano.2017.07.002 · 2017
Current hurdles to the translation of nanomedicines from bench to the clinic
10.1007/s13346-021-01024-2 · 2022
Folate receptor–targeted aminoglycoside–derived polymers for transgene expression in cancer cells
10.1002/btm2.10038 · 2016
Emerging nanomedicine strategies for hepatocellular carcinoma therapy
10.1002/imo2.12 · 2024
Tumor microenvironment–responsive histidine modified–hyaluronic acid–based MnO2 as in vivo MRI contrast agent
10.1016/j.ijbiomac.2022.12.033 · 2023
Erythrocyte membrane–camouflaged doxorubicin nanoparticles for enhancing therapeutic efficacy in primary liver cancer
2026
Mitigating doxorubicin–induced cardiotoxicity and enhancing anti–tumor efficacy with a metformin–integrated self–assembled nanomedicine
2025
Catalpol ameliorates doxorubicin-induced inflammation and oxidative stress in H9C2 cells through PPAR–γ activation
10.3892/etm.2020.8743 · 2020
Folate receptor-targetable and tumor microenvironment-responsive manganese dioxide-based nano-photosensitizer for enhancing hypoxia alleviation-triggered phototherapeutic effects
10.1016/j.jiec.2022.11.065 · 2023
A pH–responsive nanocarrier of peanut shell carbon quantum dots as a promising delivery of doxorubicin for cancer therapy
10.1038/s41598-025-06307-z · 2025
Manganese dioxide nanowires of tunable dimensions synthesized via a facile hydrothermal route
10.1155/2015/509479 · 2015
Targeting strategies for the combination treatment of cancer using drug delivery systems
10.3390/pharmaceutics9040046 · 2017
Proteomes of micro- and nanosized carriers engineered from red blood cells
10.1021/acs.jproteome.2c00695 · 2023
Recent advances in doxorubicin formulation to enhance pharmacokinetics and tumor targeting
10.3390/ph16060802 · 2023
Polydopamine–coated mesoporous silica nanoparticles for multi–responsive drug delivery and combined chemo–photothermal therapy
10.1016/j.msec.2019.110103 · 2019
Inhibition of miR–25 attenuates doxorubicin–induced apoptosis, reactive oxygen species production and DNA damage by targeting PTEN
10.7150/ijms.41980 · 2020
Imaging study of MnO2-based nanomotors modulating HIF–1α/lipid droplet biogenesis and activating the cGAS–STING pathway
10.3390/bios16050261 · 2026
Multifunctional and endogenous stimuli-responsive vinblastine sulfate/manganese dioxide nanodrugs for enhancing chemotherapeutic efficacy against hypoxic tumors
2025
Paeoniflorin–copper–coordinated nanoparticles targeting dual organelles induce lung cancer apoptosis
10.1021/acs.molpharmaceut.5c01528 · 2026
Oral delivery of a CD44–targeted polydopamine nanoplatform for synergistic chemo–chemodynamic colon cancer therapy: preparation, characterization, and in vitro study
2026
A tumor microenvironment–responsive and mannose–mediated MnO2–based nano–delivery system for synergistic targeted chemotherapy in triple–negative breast cancer
10.1016/j.nano.2026.103000 · 2026
Red blood cells based nanotheranostics: a smart biomimetic approach for fighting against cancer
10.1016/j.ijpharm.2024.124401 · 2024
Acidity and hypoxia of tumor microenvironment, a positive interplay in extracellular vesicle release by tumor cells
10.1007/s13402-024-00969-z · 2025
Hollow MnO2 nanosystem for glioblastoma sono–immunotherapy based on blood–brain barrier crossing and oxygen supply strategy
10.1016/j.jcis.2026.140834 · 2026
Poly(D,L-lactide-co-glycolide) nanoparticles encapsulating doxorubicin for improved treatment in cholangiocarcinoma and drug-resistant cells
10.1021/acsabm.5c00628 · 2025
The development and challenges of PET/MRI dual–modality imaging probes—an update
10.1002/jmri.29779 · 2025
Betaine ameliorates doxorubicin–induced cardiomyopathy by inhibiting oxidative stress, inflammation, and fibrosis through the modulation of AMPK/Nrf2/TGF–β expression
10.1002/tox.24291 · 2024
Biomedical applications of MnO2 nanomaterials as nanozyme–based theranostics
10.1016/j.biopha.2023.114833 · 2023
PEGylation of metal oxide nanoparticles modulates neutrophil extracellular trap formation
10.3390/bios12020123 · 2022
